Stena Sessan AB

Stena Sessan AB is a Swedish private investment firm that specializes in creating long-term value through responsible investments in companies with significant growth potential. The firm operates with a flexible investment strategy and a long-term horizon, aiming to develop businesses that can address future needs and challenges. By investing as a minority shareholder, Stena Sessan seeks to be an active owner, collaborating with knowledgeable co-investors, entrepreneurs, and management teams to foster sustainable growth.

The firm's investment approach is sector-agnostic, focusing on Nordic companies with leading market positions and strong management teams. Stena Sessan has a history of investments in various sectors, including technology, healthcare, and real estate. Notable investments include a 21% stake in Swedish pharmaceutical company Meda, which was sold to Mylan in August 2016, and significant holdings in Scandic Hotels and Concordia Maritime. The firm also owns residential properties in Gothenburg, Stockholm, and Uppsala through its subsidiary, Stena Sessan Fastighets AB.

Stena Sessan's mission is to develop a future-proof and well-diversified portfolio by making responsible investments and active ownership in companies with the potential for development over generations. The firm's vision, known as 2X5Y, aims to double the value of its investments every five years, reflecting a continuous and long-term commitment to building strong, growing, and profitable businesses. This objective requires collaboration with entrepreneurs and other co-owners to create value over time and meet the needs and challenges of the future.